Data / Form D filings / Templar Nova, Inc.
Templar Nova, Inc.: Form D filing
Templar Nova, Inc., a biotechnology company in Rockville, MD, filed a Form D with the SEC in 2026. The latest, on October 7, 2026, reports $7 million sold of a $7 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 13701 VALLEY OAK CIRCLE, Rockville, MD, 20850
- Phone
- (410) 868-9592
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2026
- Revenue range
- Not Applicable
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2158642
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 7 | New notice | $7,000,000 | $7,000,000 | 2 | Sep 28 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Xi Steven Chen | Executive Officer | General Counsel |
Other biotechnology companies in Maryland that filed recently
- Kaigene, Inc. $55 million · Oct 14
- Monocacy Therapeutics Inc. $25,000 · Oct 7
Every Form D from the week of Oct 5 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Templar Nova, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.